In addition, in a study of patients with type 2 diabetes, the plasma AT-III level decreased in patients with poor glycemic control, and there was a concern regarding an increased risk of thrombosis in these patients [20]. This evidence concerns the gene SERPINC1 and type 2 diabetes mellitus.